Literature DB >> 9639568

Evidence that the conformation of unliganded human plasminogen is maintained via an intramolecular interaction between the lysine-binding site of kringle 5 and the N-terminal peptide.

C S Cockell1, J M Marshall, K M Dawson, S A Cederholm-Williams, C P Ponting.   

Abstract

Human Glu-plasminogen adopts at least three conformations that provide a means for regulating the specificity of its activation in vivo. It has been proposed previously that the closed (alpha) conformation of human Glu-plasminogen is maintained through physical interaction of the kringle 5 domain and a lysine residue within the N-terminal peptide (NTP). To examine this hypothesis, site-directed mutagenesis was used to generate variant proteins containing substitutions either for aspartic acid residues within the anionic centre of the kringle 5 domain or for conserved lysine residues within the NTP. Size-exclusion HPLC and rates of plasminogen activation by urokinase-type plasminogen activator were used to determine the conformational states of these variants. Variants with substitutions within the kringle 5 lysine-binding site demonstrated extended conformations, as did variants with alanine substitutions for Lys50 and Lys62. In contrast, molecules in which NTP residues Lys20 or Lys33 were replaced were shown to adopt closed conformations. We conclude that the lysine-binding site of kringle 5 is involved in maintaining the closed conformation of human Glu-plasminogen via an interaction with the NTP, probably through Lys50 and/or Lys62. These conclusions advance the current model for the initial stages of fibrinolysis during which fibrin is thought to compete with the NTP for the kringle 5 lysine-binding site.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9639568      PMCID: PMC1219561          DOI: 10.1042/bj3330099

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  47 in total

1.  Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.

Authors:  M Hoylaerts; D C Rijken; H R Lijnen; D Collen
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

2.  Positive regulation of activation of plasminogen by urokinase: differences in Km for (glutamic acid)-plasminogen and lysine-plasminogen and effect of certain alpha, omega-amino acids.

Authors:  S W Peltz; T A Hardt; W F Mangel
Journal:  Biochemistry       Date:  1982-05-25       Impact factor: 3.162

3.  Localization of individual lysine-binding regions in human plasminogen and investigations on their complex-forming properties.

Authors:  P G Lerch; E E Rickli; W Lergier; D Gillessen
Journal:  Eur J Biochem       Date:  1980

4.  Kringle 5 of human plasminogen carries a benzamidine-binding site.

Authors:  A Váradi; L Patthy
Journal:  Biochem Biophys Res Commun       Date:  1981-11-16       Impact factor: 3.575

5.  The binding of human plasminogen to fibrin and fibrinogen.

Authors:  M A Lucas; L J Fretto; P A McKee
Journal:  J Biol Chem       Date:  1983-04-10       Impact factor: 5.157

6.  The effect of alpha-,omega-amino acids on human plasminogen structure and activation.

Authors:  B N Violand; R Byrne; F J Castellino
Journal:  J Biol Chem       Date:  1978-08-10       Impact factor: 5.157

7.  Adsorption to fibrin of native fragments of known primary structure from human plasminogen.

Authors:  S Thorsen; I Clemmensen; L Sottrup-Jensen; S Magnusson
Journal:  Biochim Biophys Acta       Date:  1981-05-29

8.  A monoclonal antibody to the epsilon-aminocaproic acid binding site on the kringle 4 region of human plasminogen that accelerates the activation of Glu1-plasminogen by urokinase.

Authors:  H S Cummings; F J Castellino
Journal:  Arch Biochem Biophys       Date:  1985-02-01       Impact factor: 4.013

9.  The solution structure of the N-terminal domain of hepatocyte growth factor reveals a potential heparin-binding site.

Authors:  H Zhou; M J Mazzulla; J D Kaufman; S J Stahl; P T Wingfield; J S Rubin; D P Bottaro; R A Byrd
Journal:  Structure       Date:  1998-01-15       Impact factor: 5.006

10.  The AH-site of plasminogen and two C-terminal fragments. A weak lysine-binding site preferring ligands not carrying a free carboxylate function.

Authors:  U Christensen
Journal:  Biochem J       Date:  1984-10-15       Impact factor: 3.857

View more
  16 in total

1.  Monoclonal antibodies detect receptor-induced binding sites in Glu-plasminogen.

Authors:  Jaena Han; Nagyung Baik; Kee-Hwan Kim; Jian-Ming Yang; Gye Won Han; Yun Gong; Mercè Jardí; Francis J Castellino; Jordi Felez; Robert J Parmer; Lindsey A Miles
Journal:  Blood       Date:  2011-06-16       Impact factor: 22.113

2.  Skizzle is a novel plasminogen- and plasmin-binding protein from Streptococcus agalactiae that targets proteins of human fibrinolysis to promote plasmin generation.

Authors:  Karen G Wiles; Peter Panizzi; Heather K Kroh; Paul E Bock
Journal:  J Biol Chem       Date:  2010-04-30       Impact factor: 5.157

3.  Fibrinolytic cross-talk: a new mechanism for plasmin formation.

Authors:  Tiphaine Dejouvencel; Loïc Doeuvre; Romaric Lacroix; Laurent Plawinski; Françoise Dignat-George; H Roger Lijnen; Eduardo Anglés-Cano
Journal:  Blood       Date:  2009-12-07       Impact factor: 22.113

4.  Rapid binding of plasminogen to streptokinase in a catalytic complex reveals a three-step mechanism.

Authors:  Ingrid M Verhamme; Paul E Bock
Journal:  J Biol Chem       Date:  2014-08-19       Impact factor: 5.157

5.  Effects on human plasminogen conformation and activation rate caused by interaction with VEK-30, a peptide derived from the group A streptococcal M-like protein (PAM).

Authors:  Mariana Figuera-Losada; Marie Ranson; Martina L Sanderson-Smith; Mark J Walker; Francis J Castellino; Mary Prorok
Journal:  Biochim Biophys Acta       Date:  2010-02-10

6.  Reduction of canine plasminogen leads to an expanded molecule which precipitates.

Authors:  Jack A Kornblatt
Journal:  PLoS One       Date:  2009-07-10       Impact factor: 3.240

7.  Canine plasminogen: spectral responses to changes in 6-aminohexanoate and temperature.

Authors:  Jack A Kornblatt; Tanya A Barretto; Ketevan Chigogidze; Bahati Chirwa
Journal:  Anal Chem Insights       Date:  2007-03-22

Review 8.  Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?

Authors:  Michael B Boffa; Marlys L Koschinsky
Journal:  J Lipid Res       Date:  2015-12-08       Impact factor: 5.922

9.  Rapid-reaction kinetic characterization of the pathway of streptokinase-plasmin catalytic complex formation.

Authors:  Ingrid M Verhamme; Paul E Bock
Journal:  J Biol Chem       Date:  2008-07-25       Impact factor: 5.157

10.  Structural basis of hepatocyte growth factor/scatter factor and MET signalling.

Authors:  Ermanno Gherardi; Sara Sandin; Maxim V Petoukhov; John Finch; Mark E Youles; Lars-Göran Ofverstedt; Ricardo N Miguel; Tom L Blundell; George F Vande Woude; Ulf Skoglund; Dmitri I Svergun
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.